IMELASOMERAN
UNII 5295LF55B6

Substance Identification & Data

This profile provides standardized clinical and technical data for Imelasomeran, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5295LF55B6.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2763208-92-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
5295LF55B6
CAS Registry Number
2763208-92-8
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
IMELASOMERAN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C188744
National Cancer Institute reference terminology for clinical and research data.
INN ID
12625
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
nucleicAcid
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Imelasomeran. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

IMELASOMERAN

Common Names & Synonyms

IMELASOMERAN [INN]
IMELASOMERAN [WHO-DD]
MESSENGER RNA (MRNA), 5'-CAPPED, ENCODING A FULL-LENGTH, CODON-OPTIMISED PRE-FUSION STABILISED CONFORMATION VARIANT (K983P AND V984P) OF THE SARS-COV-2 (SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2) SPIKE (S) GLYCOPROTEIN (OMICRON VARIANT, B.1.1.529; BASED UPON GISAID NO. EPI_ISL_6640919), FURTHER OPTIMIZED BY TWO ADDITIONAL STOP CODONS, FLANKED BY AN ARTIFICIAL 5' UNTRANSLATED REGION (UTR) AND A 3' UTR DERIVED FROM THE HUMAN ALPHA GLOBIN GENE (HBA1) AND TERMINATED BY A 3' POLY(A) TAIL; CONTAINS N1-METHYLPSEUDOURIDINE INSTEAD OF URIDINE (ALL-U>M 1.PSI.)
RNA (RECOMBINANT 5'-(M7G-(5'->5')-PPP-GM)-CAPPED ALL URIDINE->N1-METHYLPSEUDOURIDINE-SUBSTITUTED SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 PRE-FUSION SPIKE GLYCOPROTEIN B.1.1.529 VARIANT PLUS 5'-AND 3'-UNTRANSLATED FLANKING REGION-CONTAINING POLY(A)-TAILED MESSENGER CX-031302), INNER SALT

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus